Krystal Biotech KRYS
NASDAQ KRYS
$322.45 -2.86 (-0.88%)
As of: Oct 2, 2026 · 2:31 PM EDT

Krystal Biotech (KRYS) Return on Assets [ROA] (2017 - 2026)

Updated

Krystal Biotech (KRYS) posted Return on Assets [ROA] of 16.67% for Q2 2026, up 3.41 percentage points from 13.26% a year earlier and up 0.19 percentage points from the prior quarter.

Analysis

Krystal Biotech (KRYS) Return on Assets [ROA] (2017 - 2026) Analysis & Trends

For FY2025, Krystal Biotech's Return on Assets [ROA] came in at 17.14%, up 7.63 percentage points from FY2024.

  • Annual Return on Assets [ROA] has increased for three consecutive years, with a five-year change of +29.84 percentage points (FY2020 to FY2025).
  • In prior years, Krystal Biotech's Return on Assets [ROA] was 9.51% in FY2024 (+7.93 pp), 1.59% in FY2023 (+25.22 pp), -23.63% in FY2022 (-8.78 pp) and -14.85% in FY2021 (-2.15 pp).
  • Quarterly Return on Assets [ROA] has run from a low of -26.38% in Q1 2023 to a high of 16.73% in Q3 2025 over five years.
  • On a year-over-year basis, Return on Assets [ROA] has increased in each of the last 12 quarters, with an average year-over-year change of +6.37 percentage points over the last eight quarters.
  • The strongest year-over-year quarter for Return on Assets [ROA] in the past five years was Q2 2024, with a gain of 36.35 percentage points; the weakest was Q4 2022, with a drop of 12.64 percentage points.
  • According to Business Quant data, Return on Assets [ROA] for the three prior quarters was 16.48% (Q1 2026), 15.91% (Q4 2025) and 16.73% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 10.47%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 4.65%
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 2.45%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 28.37%
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 9.10%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 9.29%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -6.13%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 2.14%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 16.34%
10 Krystal Biotech 9.84 Bn 6.61 Bn 112.79 Mn 16.67%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 16.67%
Mar 31, 2026 16.48%
Dec 31, 2025 15.91%
Sep 30, 2025 16.73%
Jun 30, 2025 13.26%
Mar 31, 2025 11.64%
Dec 31, 2024 8.75%
Sep 30, 2024 5.51%
Jun 30, 2024 11.96%
Mar 31, 2024 6.84%
Dec 31, 2023 0.92%
Sep 30, 2023 -4.89%
Jun 30, 2023 -24.39%
Mar 31, 2023 -26.38%
Dec 31, 2022 -25.59%
Sep 30, 2022 -22.47%
Jun 30, 2022 -19.13%
Mar 31, 2022 -16.75%
Dec 31, 2021 -12.95%
Sep 30, 2021 -13.04%
API Access

Krystal Biotech Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=KRYS&period=max&api_key=YOUR_API_KEY